Completed NCT01686724
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
In San Francisco ADHD Behavioral From 7 Years to 11 Years
Countries United States
Sponsor University of California, San Francisco
Condition ADHD Unknown NCT06221865
This summary needs review. Please check the official study record and contact the research team for details.
In Clermont-Ferrand PTSD Other From 18 Years to 50 Years
Countries France
Sponsor University Hospital, Clermont-Ferrand
Condition PTSD Terminated NCT04804358
This study was terminated in France. It focuses on Eating disorders.
In Montpellier Eating disorders Behavioral From 18 Years to 65 Years
Countries France
Sponsor University Hospital, Montpellier
Condition Eating disorders Completed NCT03945175
This study is completed in the United States. It focuses on ADHD.
In New York ADHD Drug i A study involving a medication or substance. From 18 Years to 60 Years
Countries United States
Sponsor NYU Langone Health
Condition ADHD Completed NCT00561340
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
In Omaha ADHD Behavioral From 5 Years to 9 Years
Countries United States
Sponsor University of Nebraska
Condition ADHD Withdrawn NCT02286206
This summary needs review. Please check the official study record and contact the research team for details.
In Vancouver Schizophrenia Drug From 19 Years to 65 Years
Countries Canada
Sponsor University of British Columbia
Condition Schizophrenia Completed NCT00989950
This summary needs review. Please check the official study record and contact the research team for details.
In Springfield ADHD Drug From 6 Years to 12 Years
Countries United States
Sponsor Cox Health Systems
Condition ADHD Completed NCT00934466
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Schizophrenia Drug From 18 Years to 40 Years
Countries
Sponsor Merck Sharp & Dohme LLC
Condition Schizophrenia Completed NCT04610931
This summary needs review. Please check the official study record and contact the research team for details.
In Clermont-Ferrand Addiction Behavioral From 18 Years to 75 Years
Countries France
Sponsor University Hospital, Clermont-Ferrand
Condition Addiction Completed NCT01396421
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Canada, Japan, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Active Not Recruiting NCT04106102
This summary needs review. Please check the official study record and contact the research team for details.
In Nice OCD Device i A study involving a tool, app, wearable, test, or medical device. Over 18 Years
Countries France
Sponsor Centre Hospitalier Universitaire de Nice
Condition OCD Completed NCT05859698
This study is completed in the United States. It focuses on adults with tardive dyskinesia.
Multiple locations, including Bryant Schizophrenia, Depression, ... Drug Over 18 Years
Countries United States
Sponsor Neurocrine Biosciences
Condition Schizophrenia, Depression, ...